FDAFDA · Food and drugs·Recall number D-0342-2021
Cephalexin for Oral Suspension, Generic for Keflex, USP, Powder for Oral Suspension, 250 mg/5mL, Pkg Size 100, Rx only, Repackaged by Preferred Pharmaceuticals, Inc., Mfg: Ascend Laboratories, LLC, NDC #: 68788-7529-1,
Published May 5, 2021 · Recall initiated: April 12, 2021
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/degradation specifications: Repackager recall due to Out of Specification detected by manufacturer for Individual Unidentified Impurity found during related substance test analysis of Cephalexin
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- CEPHALEXIN
- Manufacturer
- Preferred Pharmaceuticals, Inc.
- Distributor
- recalled product was distributed to three physicians located CA
- Lot
- Lot #: B1121W, Exp.Date: 04/2022
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.